PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO.JK)
IDR 555.0
(-2.63%)
IDR 555.0
(-2.63%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 504.76 Billion IDR | -12.36% |
| 2022 | 575.96 Billion IDR | -3.65% |
| 2021 | 597.78 Billion IDR | -4.78% |
| 2020 | 627.77 Billion IDR | 32.95% |
| 2019 | 472.19 Billion IDR | 8.55% |
| 2018 | 435.01 Billion IDR | 65.83% |
| 2017 | 262.33 Billion IDR | 14.19% |
| 2016 | 229.72 Billion IDR | 16.14% |
| 2015 | 197.79 Billion IDR | 5.92% |
| 2014 | 186.74 Billion IDR | -42.73% |
| 2013 | 326.05 Billion IDR | -61.48% |
| 2012 | 846.34 Billion IDR | 33.64% |
| 2011 | 633.31 Billion IDR | 16.46% |
| 2010 | 543.79 Billion IDR | 26.59% |
| 2009 | 429.56 Billion IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 353.83 Billion IDR | -23.2% |
| 2024 Q1 | 460.72 Billion IDR | -8.72% |
| 2024 Q3 | 306.33 Billion IDR | -13.43% |
| 2023 Q2 | 300.39 Billion IDR | -72.76% |
| 2023 Q1 | 1102.79 Billion IDR | 91.47% |
| 2023 FY | 504.76 Billion IDR | -12.36% |
| 2023 Q4 | 504.76 Billion IDR | 46.11% |
| 2023 Q3 | 345.46 Billion IDR | 15.0% |
| 2022 FY | 575.96 Billion IDR | -3.65% |
| 2022 Q4 | 575.96 Billion IDR | 69.3% |
| 2022 Q1 | 1199.72 Billion IDR | 100.7% |
| 2022 Q3 | 340.19 Billion IDR | 0.89% |
| 2022 Q2 | 337.18 Billion IDR | -71.89% |
| 2021 Q2 | 427.92 Billion IDR | -60.3% |
| 2021 Q1 | 1077.82 Billion IDR | 71.69% |
| 2021 FY | 597.78 Billion IDR | -4.78% |
| 2021 Q4 | 597.78 Billion IDR | 1.8% |
| 2021 Q3 | 587.23 Billion IDR | 37.23% |
| 2020 Q3 | 394.95 Billion IDR | 7.76% |
| 2020 Q1 | 439.7 Billion IDR | -6.88% |
| 2020 Q4 | 627.77 Billion IDR | 58.95% |
| 2020 FY | 627.77 Billion IDR | 32.95% |
| 2020 Q2 | 366.52 Billion IDR | -16.64% |
| 2019 Q1 | 375.68 Billion IDR | -13.64% |
| 2019 FY | 472.19 Billion IDR | 8.55% |
| 2019 Q3 | 365.42 Billion IDR | 20.12% |
| 2019 Q2 | 304.21 Billion IDR | -19.02% |
| 2019 Q4 | 472.19 Billion IDR | 29.22% |
| 2018 FY | 435.01 Billion IDR | 65.83% |
| 2018 Q4 | 435.01 Billion IDR | 53.2% |
| 2018 Q3 | 283.94 Billion IDR | -61.62% |
| 2018 Q2 | 739.77 Billion IDR | 176.97% |
| 2018 Q1 | 267.09 Billion IDR | 1.81% |
| 2017 Q1 | 202.13 Billion IDR | -12.01% |
| 2017 Q2 | 185.69 Billion IDR | -8.14% |
| 2017 Q3 | 233.12 Billion IDR | 25.55% |
| 2017 Q4 | 262.33 Billion IDR | 12.53% |
| 2017 FY | 262.33 Billion IDR | 14.19% |
| 2016 Q3 | 224.46 Billion IDR | 2.74% |
| 2016 FY | 229.72 Billion IDR | 16.14% |
| 2016 Q4 | 229.72 Billion IDR | 2.35% |
| 2016 Q2 | 218.48 Billion IDR | -1.95% |
| 2016 Q1 | 222.83 Billion IDR | 12.66% |
| 2015 Q1 | 153.37 Billion IDR | -17.87% |
| 2015 FY | 197.79 Billion IDR | 5.92% |
| 2015 Q4 | 197.79 Billion IDR | 9.93% |
| 2015 Q3 | 179.92 Billion IDR | 2.51% |
| 2015 Q2 | 175.51 Billion IDR | 14.43% |
| 2014 Q4 | 186.74 Billion IDR | 6.57% |
| 2014 Q3 | 175.22 Billion IDR | -19.3% |
| 2014 Q2 | 217.11 Billion IDR | 6.09% |
| 2014 Q1 | 204.65 Billion IDR | -37.23% |
| 2014 FY | 186.74 Billion IDR | -42.73% |
| 2013 Q2 | 326.18 Billion IDR | 0.0% |
| 2013 Q1 | - IDR | 0.0% |
| 2013 FY | 326.05 Billion IDR | -61.48% |
| 2013 Q4 | 326.05 Billion IDR | 0.0% |
| 2012 FY | 846.34 Billion IDR | 33.64% |
| 2011 FY | 633.31 Billion IDR | 16.46% |
| 2010 FY | 543.79 Billion IDR | 26.59% |
| 2009 FY | 429.56 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 639.05 Billion IDR | 21.014% |
| PT Merck Tbk | 161.93 Billion IDR | -211.708% |
| PT Phapros, Tbk | 995.56 Billion IDR | 49.298% |
| PT Pyridam Farma Tbk | 1164.17 Billion IDR | 56.642% |
| PT Tempo Scan Pacific Tbk | 3250.09 Billion IDR | 84.469% |